Mortality in Patients With Right Bundle-Branch Block in the Absence of Cardiovascular Disease.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
20 10 2020
Historique:
pubmed: 15 9 2020
medline: 16 3 2021
entrez: 14 9 2020
Statut: ppublish

Résumé

Background Right bundle-branch block (RBBB) occurs in 0.2% to 1.3% of people and is considered a benign finding. However, some studies have suggested increased risk of cardiovascular morbidity and mortality. We sought to evaluate risk attributable to incidental RBBB in patients without prior diagnosis of cardiovascular disease (CVD). Methods and Results We reviewed the Mayo Clinic Integrated Stress Center database for exercise stress tests performed from 1993 to 2010. Patients with no known CVD-defined as absence of coronary disease, structural heart disease, heart failure, or cerebrovascular disease-were selected. Only Minnesota residents were included, all of whom had full mortality and outcomes data. There were 22 806 patients without CVD identified; 220 of whom (0.96%) had RBBB, followed for 6 to 23 years (mean 12.4±5.1). There were 8256 women (36.2%), mean age was 52±11 years; and 1837 deaths (8.05%), including 645 cardiovascular-related deaths (2.83%), occurred over follow-up. RBBB was predictive of all-cause (hazard ratio [HR], 1.5; 95% CI, 1.1-2.0;

Identifiants

pubmed: 32924743
doi: 10.1161/JAHA.120.017430
pmc: PMC7792408
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e017430

Commentaires et corrections

Type : CommentIn

Références

PLoS One. 2013 Oct 31;8(10):e78808
pubmed: 24205321
Am J Cardiol. 2011 Feb 15;107(4):540-4
pubmed: 21184999
J Ultrasound Med. 2015 Dec;34(12):2171-7
pubmed: 26491093
Heart Views. 2015 Oct-Dec;16(4):137-43
pubmed: 26900418
Postgrad Med J. 2016 Aug;92(1090):487-8
pubmed: 26984674
Circulation. 2009 Mar 17;119(10):e235-40
pubmed: 19228822
J Am Heart Assoc. 2020 Oct 20;9(19):e017430
pubmed: 32924743
Eur Heart J. 2012 Jan;33(1):86-95
pubmed: 21890488
J Am Coll Cardiol. 1997 Oct;30(4):1046-51
pubmed: 9316537
Circulation. 2016 Aug 30;134(9):656-65
pubmed: 27507405
Ann Clin Res. 1971 Dec;3(6):323-32
pubmed: 5156892
Int J Cardiol. 2005 Jul 10;102(2):303-8
pubmed: 15982501
Eur Heart J. 2013 Jan;34(2):138-46
pubmed: 22947613
Am J Cardiol. 2016 Mar 1;117(5):754-9
pubmed: 26762726
Am J Cardiol. 2010 Mar 1;105(5):677-80
pubmed: 20185016
Circulation. 2002 Oct 1;106(14):1883-92
pubmed: 12356646
Am J Cardiol. 2012 Nov 15;110(10):1489-95
pubmed: 22858187

Auteurs

Prakriti Gaba (P)

Department of Medicine Columbia University Medical Center New York NY.

Dawn Pedrotty (D)

Department of Medicine Hospital of the University of Pennsylvania Philadelphia PA.

Christopher V DeSimone (CV)

Department of Cardiovascular Medicine Mayo Clinic College of Medicine Rochester MN.

Amanda R Bonikowske (AR)

Department of Cardiovascular Medicine Mayo Clinic College of Medicine Rochester MN.

Thomas G Allison (TG)

Department of Cardiovascular Medicine Mayo Clinic College of Medicine Rochester MN.

Suraj Kapa (S)

Department of Cardiovascular Medicine Mayo Clinic College of Medicine Rochester MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH